Cellectar Biosciences Files 8-K
Ticker: CLRB · Form: 8-K · Filed: May 1, 2025 · CIK: 1279704
| Field | Detail |
|---|---|
| Company | Cellectar Biosciences, Inc. (CLRB) |
| Form Type | 8-K |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, regulatory-filing
TL;DR
Cellectar filed an 8-K with financial updates, nothing major to see here.
AI Summary
Cellectar Biosciences, Inc. filed an 8-K report on May 1, 2025, detailing events as of April 30, 2025. The filing primarily concerns financial statements and exhibits, with no specific material events or transactions disclosed in the provided excerpt.
Why It Matters
This 8-K filing indicates that Cellectar Biosciences is providing updated financial statements and exhibits to the SEC, which is a standard regulatory requirement.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, not indicating any immediate material changes or risks.
Key Numbers
- 1-36598 — SEC File Number (Identifies the company's filing with the SEC.)
- 04-3321804 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Cellectar Biosciences, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Florham Park, NJ (location) — Principal executive offices address
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report financial statements and exhibits as of April 30, 2025.
When was this 8-K report filed with the SEC?
This 8-K report was filed with the SEC on May 1, 2025.
What is the exact name of the company filing this report?
The exact name of the company filing this report is Cellectar Biosciences, Inc.
In which state is Cellectar Biosciences, Inc. incorporated?
Cellectar Biosciences, Inc. is incorporated in Delaware.
What is the principal executive office address for Cellectar Biosciences, Inc.?
The principal executive office address for Cellectar Biosciences, Inc. is 100 Campus Drive, Florham Park, NJ, 07932.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding Cellectar Biosciences, Inc. (CLRB).